Koers Sartorius Stedim Biotech SA Euronext Paris
Aandelen
STDM
FR0000053266
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
||
- EUR | - |
23/04 | SARTORIUS STEDIM BIOTECH : Barclays herhaalt het Neutraal advies | ZD |
23/04 | SARTORIUS STEDIM BIOTECH : UBS vindt het aandeel niet inspirerend | ZM |
Omzet 2024 * | 2,94 mld. 3,17 mld. | Omzet 2025 * | 3,35 mld. 3,61 mld. | Marktkapitalisatie | 20,02 mld. 21,56 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 343 mln. 370 mln. | Nettowinst (verlies) 2025 * | 459 mln. 494 mln. | EV/omzet 2024 * | 7,58 x |
Nettoschuld 2024 * | 2,27 mld. 2,44 mld. | Nettoschuld 2025 * | 2,15 mld. 2,32 mld. | EV/omzet 2025 * | 6,62 x |
K/w-verhouding 2024 * |
57
x | K/w-verhouding 2025 * |
41,1
x | Werknemers | - |
Dividendrendement 2024 * |
0,36% | Dividendrendement 2025 * |
0,54% | Vrij verhandelbaar | 31,97% |
Recentste transcriptie over Sartorius Stedim Biotech SA
Managers | Titel | Leeftijd | Van |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 26-03-19 |
Chairman | 59 | 29-06-07 | |
Chief Tech/Sci/R&D Officer | 59 | 29-04-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 29-06-07 |
Chairman | 59 | 29-06-07 | |
Susan Dexter
BRD | Director/Board Member | 67 | 07-04-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,84% | 182 mld. | |
+0,56% | 110 mld. | |
-3,35% | 68,11 mld. | |
+2,39% | 50,53 mld. | |
+9,36% | 44,8 mld. | |
+2,70% | 40,7 mld. | |
+24,51% | 32,3 mld. | |
+3,43% | 26,53 mld. | |
+13,67% | 25,02 mld. |